General Actions (Not specific medical benefits for the user)
| Core Action | Mechanism |
| Inhibits Platelet Aggregation | Ticagrelor binds directly to the $\text{P2Y}_{12}$ receptor on the platelet surface, preventing the binding of ADP and thus inhibiting platelet activation and aggregation (clumping). |
| Prevents Clot Formation | By keeping platelets separate, it significantly reduces the risk of forming occlusive blood clots in the coronary arteries, which are the primary cause of heart attacks and strokes in ACS patients. |
| Reduces Cardiovascular Mortality | Clinical trials have shown that Ticagrelor, when used with aspirin, leads to a reduction in the rate of cardiovascular death and recurrent major adverse cardiovascular events (MACE). |
| Rapid and Reversible Action | Unlike some other P2Y12 inhibitors, Ticagrelor's action is rapid and reversible, which can be beneficial in certain urgent surgical situations (though it still carries a significant bleeding risk). |
⚠️ Important Safety Note:
Ticacard 90mg Tablet is a potent prescription medication. This drug increases the risk of bleeding, which can be severe and fatal.
Offer Products
Face Care
Hair Care
stationery & office
Tea & Coffee
Baby Wipes
Cream
Baby Essentials
Fragrances
Lip Care
Body Care
Air Freshener
Customer questions & answers
Customer reviews
0 out of 5